Turkish Journal of Hematology (Sep 2024)
Anti-CD22 Calicheamicin-Inotuzumab Ozogamicin Combined with Venetoclax + Azacitidine in the Treatment of Mixed-Phenotype Acute Leukemia: A Case Report
Abstract
No abstracts available.Keywords
Turkish Journal of Hematology (Sep 2024)